Glenmark Investigational Site 46 — Wilmington, North Carolina

Glenmark Investigational Site 46 is a clinical research site located in Wilmington, North Carolina, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Glenmark Investigational Site 46 has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis.

Sponsors: Glenmark Pharmaceuticals Ltd. India.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Glenmark Investigational Site 46?

Glenmark Investigational Site 46 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Glenmark Investigational Site 46 conducted?

Glenmark Investigational Site 46 has 1 clinical trials on record. Their work covers Atopic Dermatitis.

Is Glenmark Investigational Site 46 accredited by Crixeo Health?

Glenmark Investigational Site 46 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Glenmark Investigational Site 46?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.